Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Alzheimer'S Research & Therapy|November 30, 2021
Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brainXiangpei Yue, Yanzhao Zhou, Meng Qiao, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 20, 2014
Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysmZhanjie Wei, Yu Wang, Kailun Zhang, et al.Hepatobiliary Surgery and Nutrition|August 23, 2024
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world studyJingzhong Ouyang, Yi Yang, Yanzhao Zhou, et al.Academic Radiology|July 6, 2023
MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver MetastasesYing Xu, Feng Ye, Lu Li, et al.Journal of Neuroscience Methods|February 22, 2015
A method for establishing the high-altitude cerebral edema (HACE) model by acute hypobaric hypoxia in adult miceXin Huang, Yanzhao Zhou, Tong Zhao, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 30, 2023
A novel vaccine targeting β1-adrenergic receptorFan Ke, Wenlong Kuang, Xiajun Hu, et al.Scientific Reports|October 5, 2017
Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive VaccineXiajun Hu, Yihuan Deng, Xiao Chen, et al.Plos One|October 15, 2015
Reduced Cerebral Oxygen Content in the DG and SVZ In Situ Promotes Neurogenesis in the Adult Rat Brain In VivoKuan Zhang, Yanzhao Zhou, Tong Zhao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025
PLAUR<sup>+</sup> Neutrophils Drive Anti-PD-1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive MicroenvironmentShaoqing Liu, Yanzhao Zhou, Gaoxiang Li, et al.International Immunopharmacology|March 30, 2024
The novel vaccines targeting interleukin-1 receptor type IYanzhao Zhou, Jianwu Huang, Wuqian Mai, et al.Pageof 7